Fundamental research to counter weapons of mass destruction (c-WMD)

Ended Project Grant Awarded Last action

Award ID
HDTRA12010010
Recipient
Awarding agency
Obligated
$1,465,845

Award facts

Assistance listing
12.351 Scientific Research - Combating Weapons of Mass Destruction
Completion date
Originally
Funding agency
Defense Threat Reduction Agency Department of Defense
Place of performance
San Diego, CA 92121, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Deobligation of excess funds -$78,607
Amendment $86,632
Amendment Optimization of antibody FC region in pursuit of a pan-ebolavirus prophylactic medical countermeasure. $150,000
Amendment Modification to change the PI. $0
Amendment Optimization of antibody FC region in pursuit of a pan-ebolavirus prophylactic medical countermeasure $0
Amendment $277,822
Amendment Research and development for optimization of antibody FC region in pursuit of a pan-ebolavirus prophylactic medical countermeasure $57,563
Amendment $272,054
Amendment $300,000
Original award $400,380

Quick answers

Who received award HDTRA12010010?

HDTRA12010010 was awarded to Mapp Biopharmaceutical, Inc. by Defense Contract Management Agency (Department of Defense) on June 15, 2020.

How much is award HDTRA12010010 worth?

$1,465,845 has been obligated on HDTRA12010010.

Which agency awarded HDTRA12010010?

Defense Contract Management Agency (Department of Defense) awarded HDTRA12010010, with funding from Defense Threat Reduction Agency (Department of Defense).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login